glp-1 gallstones and glp 1 Why are agonists being used to treat patients with nonalcoholic fatty liver disease? GLP-1 Medications and Gallbladder Health: – Reconciling GLP-1s and Pancreatitis

peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events

Three Legal Classifications UK medicines fall into one of three legal categories: 1

Guddat, Y

However, where you inject the medication still matters more than most people realize

While glutathione supports liver function, those with severe liver disease may need medical supervision